↓ Skip to main content

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
33 X users
patent
1 patent
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
265 Dimensions

Readers on

mendeley
191 Mendeley